Mild Hypothyroidism in Childhood: Who, When, and How Should Be Treated?

Area of Science:

• Pediatric Endocrinology
• Thyroid Disorders
• Clinical Management

Background:

• Mild hypothyroidism, or subclinical hypothyroidism (SH), is defined by elevated serum TSH with normal T4 levels.
• Specific TSH ranges define SH in neonates (6-20 mIU/L) and children (>4.5-10 mIU/L).
• The clinical significance and long-term effects of untreated SH in children remain incompletely understood.

Purpose of the Study:

• To review current evidence on the diagnosis and management of mild hypothyroidism in childhood.
• To address the challenges in determining the necessity of treatment for SH across different pediatric age groups.
• To highlight concerns regarding neurocognitive and cardiovascular outcomes in affected children.

Main Methods:

• Literature review of current evidence on diagnosis and management of mild hypothyroidism in childhood.
• Analysis of biochemical definitions of SH in neonatal and post-neonatal periods.
• Evaluation of documented effects of untreated SH on neurocognitive and cardiovascular development.

Main Results:

• SH is biochemically defined by elevated TSH and normal FT4/T4 levels.
• While neurocognitive concerns exist in neonates, subtle cardiovascular changes are noted in older children.
• Clear evidence for growth or neurocognitive impairment in children with SH is lacking.

Conclusions:

• Management of childhood SH is complex and requires individualized assessment.
• Treatment decisions should consider age, etiology, TSH levels, and patient-specific factors.
• Further research is needed to fully define the risks of untreated SH and guide optimal therapeutic strategies.